By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Where Your Profits Grow Sky High.

Valneva launches production of coronavirus vaccine

Ampoule and injection needle © Valneva

Moreover, the company, which operates a large research facility in Vienna, initiated its first clinical study with 150 participants. In the case of an inactivated vaccine, the body is confronted with viruses which have been rendered harmless. In this way, the body's own immune system deals with the pathogens and develops the necessary protective immune response. This approach has been tried and tested for a long time. The project implemented by Valneva is the only one up until now which follows this path.

The company planned and carried out the clinical development of the vaccine in Vienna. The production and quality management are organised in Austria's capital city, where more than 200 of the approx. 600 international employees work. The manufacturing operations based in Scotland will take place in parallel to the ongoing clinical studies. In the fall of 2020, Valneva reached an agreement with the British Government on supplying up to 190 million doses of its COVID-19 vaccine. If the tests of the vaccine are successful, the company will make up to 60 million doses available in the second half of 2021. Valneva is also "in advanced discussions with the European Commission" for the supply of up to 60 million doses.

Continue reading and learn more about life sciences research in Austria!

Read more:

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin



Meet us at events, seminars and trade shows - worldwide.

  • ABA's Open Day 2021: Austria - Your ICT and Innovation Hub in the Heart of Europe

    11 March 2021/ 09.00am + 05.00 pm, Online Conference

  • Meet us @ International Machinery Forum 2021 - The Factory of Tomorrow

    11.03 - 12.03 2021, Online Conference

Austria Map

Find the perfect location for your company

Vienna is a beautiful city and a natural place to be for Trask. We are happy that we can introduce our great technology expertise together with revolutionary ready-to-use solutions to Austrian banks. And thanks to the cooperation with ABA everything is a bit easier.

Daniel Pecina, CEO Trask Austria GmbH

trask logo
More testimonials

news from the business location Austria

OMV and Kommunalkredit invest in the production of green hydrogen

The Austrian oil and gas company OMV and Kommunalkredit Austria AG (Kommunalkredit) have announced a joint investment in the construction of Austria’s largest electrolysis plant to be located in the OMV Schwechat Refinery.

Evotec SE

Evotec is an active substance research company which rapidly presses ahead with innovative product approaches on the basis of development partnerships with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.

More news All blog posts